Dr. ID: 40302
Sarah Jane Pauline Minner
Publications
- 2014
Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer
Krohn, A., Freudenthaler, F., Harasimowicz, S., Kluth, M., Fuchs, S., Burkhardt, L., Stahl, P., C Tsourlakis, M., Bauer, M., Tennstedt, P., Graefen, M., Steurer, S., Sirma, H., Sauter, G., Schlomm, T., Simon, R. & Minner, S., 25.04.2014, In: MODERN PATHOL. 27, 12, p. 1612-1620Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced membranous MET expression is linked to bladder cancer progression
Kluth, M., Reynolds, K., Rink, M., Chun, F., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Doh, O., Terracciano, L., Simon, R., Sauter, G. & Minner, S., 01.04.2014, In: CANCER GENET-NY. 207, 4, p. 147-52 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Gender-specific outcomes of bladder cancer patients: A stage-specific analysis in a contemporary, homogenous radical cystectomy cohort
Soave, A., Dahlem, R., Hansen, J., Weisbach, L., Minner, S., Engel, O., Kluth, L. A., Chun, F. K., Shariat, S. F., Fisch, M. & Rink, M., 13.03.2014, In: EJSO-EUR J SURG ONC. 41, 3, p. 368-377Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice
Burandt, E., Schreiber, M., Stein, A., Minner, S., Clauditz, T. S., Bokemeyer, C., Jänicke, F., Fisch, M., Izbicki, J. R., Knecht, R., Sauter, G. & Stahl, P. R., 01.03.2014, In: GENE CHROMOSOME CANC. 53, 3, p. 228-39 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions
Grupp, K., Wilking, J., Prien, K., Hube-Magg, C., Sirma, H., Simon, R., Steurer, S., Budäus, L., Haese, A., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.03.2014, In: EUR J CANCER. 50, 4, p. 852-61 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Tsourlakis, M. C., Weigand, P., Grupp, K., Kluth, M., Steurer, S., Schlomm, T., Graefen, M., Huland, H., Salomon, G., Steuber, T., Wilczak, W., Sirma, H., Simon, R., Sauter, G., Minner, S. & Quaas, A., 01.03.2014, In: AM J PATHOL. 184, 3, p. 609-17 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer
Kluth, M., Harasimowicz, S., Burkhardt, L., Grupp, K., Krohn, A., Prien, K., Gjoni, J., Hass, T., Galal, R., Graefen, M., Haese, A., Simon, R., Hühne-Simon, J., Koop, C., Korbel, J., Weischenfeld, J., Huland, H., Sauter, G., Quaas, A., Wilczak, W., Tsourlakis, M. C., Minner, S. & Schlomm, T., 13.02.2014, In: INT J CANCER. 135, 6, p. 1369-1380Research output: SCORING: Contribution to journal › SCORING: Journal article › Research
A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy
Adam, M., Hannah, A., Budäus, L., Steuber, T., Salomon, G., Michl, U., Haese, A., Fisch, M., Wittmer, C., Steurer, S., Minner, S., Heinzer, H., Huland, H., Graefen, M., Sauter, G., Schlomm, T. & Isbarn, H., 08.02.2014, In: J UROLOGY. 192, 1, p. 97-101Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR
Tennstedt, P., Bölch, C., Strobel, G., Minner, S., Burkhardt, L., Grob, T., Masser, S., Sauter, G., Schlomm, T. & Simon, R., 01.02.2014, In: INT J ONCOL. 44, 2, p. 609-15 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy
Grupp, K., Habermann, M., Sirma, H., Simon, R., Steurer, S., Hube-Magg, C., Prien, K., Burkhardt, L., Jedrzejewska, K., Salomon, G., Heinzer, H., Wilczak, W., Kluth, M., Izbicki, J. R., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.01.2014, In: MODERN PATHOL. 27, 1, p. 96-106 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse
Hennigs, J. K., Müller, J., Adam, M., Spin, J. M., Riedel, E., Graefen, M., Bokemeyer, C., Sauter, G., Huland, H., Schlomm, T. & Minner, S., 01.01.2014, In: PLOS ONE. 9, 7, p. e100469Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2013
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers
Grupp, K., Sanader, S., Sirma, H., Simon, R., Koop, C., Prien, K., Hube-Magg, C., Salomon, G., Graefen, M., Heinzer, H., Minner, S., Izbicki, J. R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 01.12.2013, In: MOL ONCOL. 7, 6, p. 1001-11 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis
Sirma, H., Broemel, M., Stumm, L., Tsourlakis, M. C., Steurer, S., Tennstedt, P., Salomon, G., Michl, U., Haese, A., Simon, R., Sauter, G., Schlomm, T. & Minner, S., 01.11.2013, In: ONCOL LETT. 6, 5, p. 1245-1252 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer
Cordes, I., Kluth, M., Zygis, D., Rink, M., Chun, F., Eichelberg, C., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Doh, O., Terracciano, L., Simon, R., Wilczak, W., Sauter, G. & Minner, S., 01.11.2013, In: HISTOPATHOLOGY. 63, 5, p. 670-7 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence
Grupp, K., Diebel, F., Sirma, H., Simon, R., Breitmeyer, K., Steurer, S., Hube-Magg, C., Prien, K., Pham, T., Weigand, P., Michl, U., Heinzer, H., Kluth, M., Minner, S., Tsourlakis, M. C., Izbicki, J. R., Sauter, G., Schlomm, T. & Wilczak, W., 01.11.2013, In: PROSTATE. 73, 15, p. 1690-8 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer
Quaas, A., Bahar, A. S., Loga, K., Seddiqi, A. S., Singer, J. M., Omidi, M., Kraus, O., Kwiatkowski, M., Trusch, M., Minner, S., Burandt, E., Stahl, P., Wilczak, W., Wurlitzer, M., Simon, R., Sauter, G., Marx, A. & Schlüter, H., 01.10.2013, In: HISTOPATHOLOGY. 63, 4, p. 455-62 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
Grupp, K., Höhne, T. S., Prien, K., Hube-Magg, C., Tsourlakis, M. C., Sirma, H., Pham, T., Heinzer, H., Graefen, M., Michl, U., Simon, R., Wilczak, W., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Steurer, S., 01.10.2013, In: EXP MOL PATHOL. 95, 2, p. 227-34 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence
Tsourlakis, M. C., Schoop, M., Plaß, C., Huland, H., Graefen, M., Steuber, T., Schlomm, T., Simon, R., Sauter, G., Sirma, H. & Minner, S., 01.09.2013, In: HUM PATHOL. 44, 9, p. 1789-96 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers
Krohn, A., Seidel, A., Burkhardt, L., Bachmann, F., Mader, M., Grupp, K., Eichenauer, T., Becker, A., Adam, M., Graefen, M., Huland, H., Kurtz, S., Steurer, S., Tsourlakis, M. C., Minner, S., Michl, U., Schlomm, T., Sauter, G., Simon, R. & Sirma, H., 01.09.2013, In: AM J PATHOL. 231, 1, p. 130-41 12 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells
Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T. & Mills, I. G., 15.08.2013, In: CANCER RES. 73, 16, p. 5277-87 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells
Kobold, S., Völk, S., Clauditz, T., Küpper, N. J., Minner, S., Tufman, A., Düwell, P., Lindner, M., Koch, I., Heidegger, S., Rothenfuer, S., Schnurr, M., Huber, R. M., Wilczak, W. & Endres, S., 01.08.2013, In: J THORAC ONCOL. 8, 8, p. 1032-42 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
Kluth, M., Hesse, J., Heinl, A., Krohn, A., Steurer, S., Sirma, H., Simon, R., Mayer, P-S., Schumacher, U., Grupp, K., Izbicki, J. R., Pantel, K., Dikomey, E., Korbel, J. O., Plass, C., Sauter, G., Schlomm, T. & Minner, S., 01.07.2013, In: MODERN PATHOL. 26, 7, p. 975-83 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer
Gannon, P. O., Lessard, L., Stevens, L-M., Forest, V., Bégin, L. R., Minner, S., Tennstedt, P., Schlomm, T., Mes-Masson, A-M. & Saad, F., 01.07.2013, In: EUR J CANCER. 49, 10, p. 2441-8 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy
Tsourlakis, M. C., Delmo Walter, E. M., Quaas, A., Graefen, M., Huland, H., Simon, R., Sauter, G., Steurer, S., Schlomm, T. & Minner, S., 01.06.2013, In: PROSTATE CANCER P D. 16, 2, p. 159-64 6 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer
Burkhardt, L., Fuchs, S., Krohn, A., Masser, S., Mader, M., Kluth, M., Bachmann, F., Huland, H., Steuber, T., Graefen, M., Schlomm, T., Minner, S., Sauter, G., Sirma, H. & Simon, R., 01.05.2013, In: CANCER RES. 73, 9, p. 2795-805 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
Flammiger, A., Weisbach, L., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 01.04.2013, In: EUR J CANCER. 49, 6, p. 1273-9 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High mitochondria content is associated with prostate cancer disease progression
Grupp, K., Jedrzejewska, K., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Quaas, A., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Schlomm, T., Minner, S. & Steurer, S., 01.01.2013, In: MOL CANCER. 12, 1, p. 145Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.
Grupp, K., Kohl, S., Sirma, H., Simon, R., Steurer, S., Becker, A., Adam, M., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 2013, In: MODERN PATHOL. 26, 5, p. 733-742 10 p., 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma.
Eichelberg, C., Chun, F., Bedke, J., Heuer, R., Adam, M., Moch, H., Terracciano, L., Hinrichs, K., Dahlem, R., Fisch, M., Schlomm, T., Sauter, G. & Minner, S. J. P., 2013, In: INT J CANCER. 132, 12, p. 2948-2955 12.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.
Jacobsen, F., Ashtiani, S. N., Tennstedt, P., Heinzer, H., Simon, R., Sauter, G., Sirma, H., Tsourlakis, M. C., Minner, S. J. P., Schlomm, T. & Michl, U., 2013, In: EXP THER MED. 5, 1, p. 102-106 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.
Weischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H-J., Stehr, H., Rausch, T., Jäger, N., Gu, L., Bogatyrova, O., Stütz, A. M., Claus, R., Eils, J., Eils, R., Gerhäuser, C., Huang, P-H., Hutter, B., Kabbe, R., Lawerenz, C., Radomski, S., Bartholomae, C. C., Fälth, M., Gade, S., Schmidt, M., Amschler, N., Hass, T., Galal, R., Gjoni, J., Kuner, R., Baer, C., Masser, S., von Kalle, C., Zichner, T., Benes, V., Raeder, B., Mader, M., Amstislavskiy, V., Avci, M., Lehrach, H., Parkhomchuk, D., Sultan, M., Burkhardt, L., Graefen, M., Huland, H., Kluth, M., Krohn, A., Sirma, H., Stumm, L., Steurer, S., Grupp, K., Sültmann, H., Sauter, G., Plass, C., Brors, B., Yaspo, M-L., Korbel, J. O. & Schlomm, T., 2013, In: CANCER CELL. 23, 2, p. 159-170 12 p., 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.
Müller, J., Ehlers, A., Burkhardt, L., Sirma, H., Steuber, T., Graefen, M., Sauter, G., Minner, S. J. P., Simon, R., Schlomm, T. & Michl, U., 2013, In: INT J CANCER. 132, 6, p. 1333-1340 6.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.
Steurer, S., Borkowski, C., Odinga, S., Buchholz, M., Koop, C., Huland, H., Becker, M., Witt, M., Trede, D., Omidi, M., Kraus, O., Bahar, A. S., Seddiqi, A. S., Singer, J. M., Kwiatkowski, M., Trusch, M., Simon, R., Wurlitzer, M., Minner, S., Schlomm, T., Sauter, G. & Schlüter, H., 2013, In: INT J CANCER. 133, 4, p. 920-928 9 p., 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Marked heterogeneity of ERG expression in large primary prostate cancers.
Minner, S., Gärtner, M., Freudenthaler, F., Bauer, M., Kluth, M., Salomon, G., Heinzer, H., Graefen, M., Bokemeyer, C., Simon, R., Sauter, G., Schlomm, T. & Wilczak, W., 2013, In: MODERN PATHOL. 26, 1, p. 106-116 11 p., 1.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.
Eichelberg, C., Minner, S., Isbarn, H., Burandt, E., Terracciano, L., Moch, H., Kell, A., Heuer, R., Chun, F. K., Sauter, G., Fisch, M. & Tennstedt, P., 2013, In: WORLD J UROL. 31, 4, p. 847-53 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.
Stumm, L., Burkhardt, L., Steurer, S., Simon, R., Adam, M., Becker, A., Sauter, G., Minner, S., Schlomm, T., Sirma, H. & Michl, U., 2013, In: J CLIN PATHOL. 66, 7, p. 563-568 6 p., 7.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2012
Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer
Flammiger, A., Bayer, F., Cirugeda-Kühnert, A., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 11.2012, In: APMIS. 120, 11, p. 901-8 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Minner, S. J. P., Lübke, A., Kluth, M., Bokemeyer, C., Jänicke, F., Izbicki, J. R., Schlomm, T., Sauter, G. & Wilczak, W., 01.09.2012, In: HISTOPATHOLOGY. 61, 3, p. 445-453 9 p., 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer
Minner, S. J. P., De Silva, C., Rink, M., Dahlem, R., Chun, F., Fisch, M., Höppner, W., Wagner, W., Bokemeyer, C., Terracciano, L., Simon, R., Sauter, G. & Wilczak, W., 08.2012, In: PATHOLOGY. 44, 5, p. 448-452 5 p., 5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
Tachezy, M., Harms-Effenberger, K., Zander, H., Minner, S. J. P., Gebauer, F., Vashist, Y., Sauter, G., Pantel, K., Izbicki, J. R. & Bockhorn, M., 15.07.2012, In: INT J CANCER. 131, 2, p. 396-405 10 p., 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer.
Krohn, A., Diedler, T., Burkhardt, L., Mayer, P. S., Colin, D. S., Meyer-Kornblum, M., Kötschau, D., Tennstedt, P., Huang, J., Gerhäuser, C., Mader, M., Kurtz, S., Sirma, H., Saad, F., Steuber, T., Graefen, M., Plass, C., Sauter, G., Simon, R., Minner, S. J. P. & Schlomm, T., 2012, In: AM J PATHOL. 181, 2, p. 401-412 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.
Schlomm, T., Tennstedt, P., Huxhold, C., Steuber, T., Salomon, G., Michl, U., Heinzer, H., Hansen, J., Budäus, L., Steurer, S., Wittmer, C., Minner, S. J. P., Haese, A., Sauter, G., Graefen, M. & Huland, H., 2012, In: EUR UROL. 62, 2, p. 333-340 2.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Rink, M., Chun, F., Dahlem, R., Soave, A., Minner, S. J. P., Hansen, J., Stoupiec, M., Coith, C., Kluth, L., Ahyai, S., Friedrich, M. G., Shariat, S. F., Fisch, M., Pantel, K. & Riethdorf, S., 2012, In: EUR UROL. 61, 4, p. 810-817 4.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Y chromosome losses are exceedingly rare in prostate cancer and unrelated to patient age.
Stahl, P., Kilgué, A., Tennstedt, P., Minner, S. J. P., Krohn, A., Simon, R., Krause, G., Izbicki, J. R., Graefen, M., Sauter, G., Schlomm, T. & Wilczak, W., 2012, In: PROSTATE. 72, 8, p. 898-903 8.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2011
Older patients suffer from adverse histopathological features after radical cystectomy
Rink, M., Dahlem, R., Kluth, L., Minner, S., Ahyai, S. A., Eichelberg, C., Fisch, M. & Chun, F. K., 08.2011, In: INT J UROL. 18, 8, p. 576-84 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
Rink, M., Chun, F., Minner, S. J. P., Friedrich, M., Mauermann, O., Heinzer, H., Huland, H., Fisch, M., Pantel, K. & Riethdorf, S., 2011, In: BJU INT. 107, 10, p. 1668-1675 10.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.
Minner, S. J. P., Enodien, M., Sirma, H., Lübke, A., Krohn, A., Mayer, P. S., Simon, R., Tennstedt, P., Müller, J., Scholz, L., Brase, J. C., Liu, A. Y., Schlüter, H., Pantel, K., Schumacher, U., Bokemeyer, C., Steuber, T., Graefen, M., Sauter, G. & Schlomm, T., 2011, In: CLIN CANCER RES. 17, 18, p. 5878-5888 18.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
Minner, S. J. P., Wittmer, C., Graefen, M., Salomon, G., Steuber, T., Haese, A., Huland, H., Bokemeyer, C., Yekebas, E. F., Dierlamm, J., Balabanov, S., Kilic, E., Wilczak, W., Simon, R., Sauter, G. & Schlomm, T., 2011, In: PROSTATE. 71, 3, p. 281-288 3.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
Minner, S. J. P., Kraetzig, F., Tachezy, M., Kilic, E., Graefen, M., Wilczak, W., Bokemeyer, C., Huland, H., Sauter, G. & Schlomm, T., 2011, In: HUM PATHOL. 42, 12, p. 1946-1952 12.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.
Stieler, K., Schindler, S., Schlomm, T., Hohn, O., Bannert, N., Simon, R., Minner, S. J. P., Schindler, M. & Fischer, N., 2011, In: PLOS ONE. 6, 10, p. 25592 10.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review